Stay updated on Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed revision identifier was updated from **v3.5.2** to **v3.5.3**, reflecting a minor software/content-portal update rather than a change to the trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:28:30.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:27.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added update dates: 2026-03-20, 2027-07, 2032-07, 2026-03-19; removed older dates: 2025-03-14, 2027-03, 2025-03-12, 2025-03.
    Difference
    0.3%
    Check dated 2026-03-26T11:31:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:58:57.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T01:43:49.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 banner. Removed the previous funding notice and the Revision: v3.4.1 banner.
    Difference
    0.4%
    Check dated 2026-02-11T13:59:19.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.